A robotic catheter system including a first drive mechanism configured to interact with an elongated medical device to cause the elongated medical device to move along its longitudinal axis. A controller provides a signal to a motor to move the first wiping surface toward the longitudinal axis when the elongated device is being withdrawn from a patient.

A deflectable medical device (1) includes a shape memory alloy wire (15) integrated into a flexible elongated body (11). The shape memory alloy wire (15) is arranged to shorten upon receiving energy from an energy supply (2,4), thereby deflecting the medical device (1). A rod (18) positioned in a lumen (14) of the flexible elongated body (11) and compressed between a fixture (16) in the proximal end (12) of the elongated body (11) and the distal end (13) of the elongated body (11) is responsible for the shape memory alloy wire (15) recovering its initial length upon discontinuation of energy supply.

Devices for establishing trans-radial access for medical intervention are described, some embodiments being optimized for consistently, safely achieving complete cerebral angiography via a single trans-radial access site. A system may include a catheter with at least two active steering sites. Some embodiments may include at least one balloon. Said steering mechanisms to help guide and support said catheter in use. In some embodiments, additional use is made of at least one vascular arch to provide further support and prevent kickback and prolapse of said catheter and any additional devices passed therethrough.

The present disclosure is in the field of medical devices and gene editing, particularly the use of medical devices for the targeted delivery of gene editing reagents in vivo or ex vivo. The methods and materials described herein provide control over the location and timing of delivery, along with the ability to deliver gene editing reagents as nucleic acids, virus particles, or protein. Furthermore, the methods and materials can be used to reduce or eliminate the systemic spread of gene editing reagents in non-target tissues/organs. The methods and devices described herein can be used for gene editing in animals.

A catheter system can include a tubular body, and at least one of a targeting system coupled to the tubular body, an expandable member, or a fluid injection port. A method of identifying a bifurcation can include inserting a catheter system into a first vessel, positioning the catheter system at a first location, expanding an expandable member to occlude the first vessel, delivering contrast material so the contrast material pooling proximate to the expandable member, and reviewing a shape of the contrast material in the first vessel under fluoroscopy.

Deflectable guide catheters and methods, including methods for using defectable guide catheters to perform transnasal procedures within the ear, nose, throat, paranasal sinuses or cranium. Some deflectable guide catheters of the present invention comprise a substantially rigid tube, a helical spring attached to and extending from the distal end of the substantially rigid tube, a tubular plastic inner jacket, an outer plastic jacket substantially covering at least the helical spring member. The spring member is deflectable to cause the distal portion of the guide catheter to deflect to a curved configuration. In embodiments for transnasal use the deflectable guide catheter may have a length of less than 25 cm.

An ablation system comprises: an ablation catheter and a console. The ablation catheter comprises: a shaft including a proximal end, a distal portion and a distal end; an ablation element configured to deliver energy to tissue; and a force maintenance assembly comprising a force maintenance element and configured to control and/or assess contact force between the ablation element and cardiac tissue. The console is configured to operably attach to the ablation catheter and comprises: an energy delivery assembly configured to provide energy to the ablation element. Methods of ablating tissue are also provided.

The present disclosure sets forth a guiding tube for placing medical implants within body tissue. The guiding tube includes an elongated, dimensionally stable tubular body encompassing an inner channel adapted to receive a medical implant wherein the tubular body has at least one electromagnetic element, the element configured to exert an electromagnetic force on at least one magnetic element of the medical implant inserted into the inner channel of the guiding tube. The medical implant includes a stimulation lead having at least one directional electrode with an elongated body insertable into an inner channel enclosed by a tubular body of the guiding tube.

An in-situ fenestration device for locating a fenestration site and for forming a fenestration. The in-situ fenestration device includes first and second magnetic locators configured to magnetically mate in a mated position within a vasculature of a patient at the fenestration site. The in-situ fenestration device also includes first and second heating elements configured to heat the first and second magnetic locators to form the fenestration at the fenestration site.

In some examples, a catheter includes an expandable member configured to expand radially outward from a collapsed configuration to an expanded configuration. The expandable member is configured to be expanded and contracted in a controlled manner, e.g., in response to user actuation or automatically under the control of control circuitry of a device. For example, in some examples, control circuitry of a device can be configured to control the expandable member to expand and contract according to a predetermined expansion frequency or according to an expansion frequency determined based on a cardiac cycle of a patient.